Wire · operational-macro
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 October 2026 · Fusion42 review
Labcorp has agreed to acquire select assets of BioReference Health from OPKO Health, including laboratory testing businesses and the proprietary FDA-approved 4Kscore Test for prostate cancer. The deal aims to expand access to specialized diagnostic services and includes over 80 patient service centers across the US.
This Wire brief sits within Fusion42's coverage of Diagnostics, and 2 sources have reported it between 15 Oct 2026 and 16 Oct 2026.
◆ ◆ The Wire takeaway
Labcorp's purchase of BioReference assets opens patient access to the 4Kscore Test nationwide, forcing diagnostic startups focused on prostate cancer to compete on scale and distribution. You need to evaluate partnerships or differentiation to avoid being sidelined by this consolidation.
◆ Coverage
2 sources · first reported 15 Oct 2026 · latest 16 Oct 2026
◆ Related on Wire
◆ Topics